To review and assess the available literature on the use of intraosseous (IO) drug administration during cardiopulmonary resuscitation, addressing the benefits and risks of using this method of drug delivery in children and adults.
Data Sources:
The MEDLINE (1950–July 2007) database was searched for pertinent abstracts, using the key term intraosseous infusions. Additional references were obtained from the bibliographies of the articles reviewed. Manufacturer Web sites were used to obtain information about IO insertion devices.
Study Selection and Data Extraction:
All available English-language clinical trials, retrospective studies, and review articles describing IO drug administration were reviewed. Studies conducted in animal models to evaluate the effectiveness and safety of IO drug administration were also included.
Data Synthesis:
IO access uses the highly vascularized bone marrow to deliver fluids and medications during cardiopulmonary resuscitation. This route, developed in the 1940s, has been revived In the past decade as a means of achieving rapid vascular access when intravenous access cannot be obtained. The primary advantage of IO access is the high success rate (approximately 80%). Most trained providers can place an IO line within 1–2 minutes. A number of small-scale studies and retrospective reviews have established the usefulness of this route for the delivery of many commonly used resuscitation drugs. In addition, animal models have demonstrated rapid drug delivery to the systemic circulation. While all resuscitation drugs can be given by the IO route, administration of ceftriaxone, chloramphenicol, Phenytoin, tobramycin, and vancomycin may result in lower peak serum concentrations. The most common adverse effect seen with IO use, extravasation, has been reported in 12% of patients. Compartment syndrome, osteomyelitis, and tibial fracture are rare, but have also been reported.
Conclusions:
IO administration is a safe and effective method for delivering drugs during cardiopulmonary resuscitation. It should be considered whenever intravenous access cannot be rapidly obtained.
1985 National Conference on Standards and Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiac Care. Standards and guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiac care (ECC). Part VI: pediatric advanced life support. JAMA1986;255:2961–4.
4.
International Liaison Committee on Resuscitation.The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support. Pediatrics2006;117:955–77. Epub 17 Apr 2006. DOI 10.1542/peds. 2006–0206
5.
American Heart Association.2005American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care (ECC) of pediatric and neonatal patients: pediatric advanced life support. Pediatrics2006;117:1005–28. DOI 10.1542/peds.2006–0346
6.
MillerL, KramerGC, BolleterS.Rescue access made easy: intraosseous infusion, once limited to use on children, is now becoming a reliable access site for adults. J Emerg Med Serv JEMS2005;30(suppl):8–18.
7.
International Liaison Committee on Resuscitation.2005International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Part 4: advanced life support. Resuscitation2005;67:213–47. DOI 101016/j.resuscitation.2005.09.018
8.
BrunetteDDFischerR.Intravenous access in pediatric cardiac arrest. Am J Emerg Med1988;6:577–9. DOI 10.1016/0735-6757(88)90094-0
9.
UmmenhoferW, FreiFJ, UrwylerA, DreweJ.Are laboratory values in bone marrow aspirate predictable for venous blood in pediatric patients?Resuscitation1994;27:123–8. DOI 10.1016/0300–9572(94)90004-3
10.
TocantinsLM, O'NeillJF, JonesHW. Infusions of blood and other fluids via the bone marrow. JAMA1941;117:1229–34.
11.
OrlowskiJP. Emergency alternatives to intravenous access: intraosseous, intratracheal, sublingual, and other-site drug administration. Pediatr Clin North Am1994;41:1183–99.
12.
RosettiVA, ThompsonBM, MillerJ, MateerJR, AprahamianC.Intraosseous infusion: an alternative route of pediatric intravascular access. Ann Emerg Med1985;14:885–8. DOI 10.1016/S0196-0644(85):80639-9
13.
SpiveyWH. Intraosseous infusions. J Pediatr1987;111:639–43. DOI 10.1016/S0022-3476(87)80236–6
14.
Product information. FAST1 Adult Intraosseous Infusion System. Richmond, British Columbia: Pyng Medical Corporation, 2007. www.pyng.com (accessed 2007 Jun 23).
15.
Product information. The Bone Injection Gun. Houston, TX: WaisMed, 2006. www.waismed.com (accessed 2007 Jun 23).
16.
Product information. The EZ-IO. San Antonio, TX: The VidaCare Corporation, 2006. www.vidacare.com (accessed 2007 Jun 23).
17.
MacnabA, ChristensonJ, FindlayJ, . A new system for sternal intraosseous infusion in adults. Prehosp Emerg Care2000;4:173–7. DOI 10.1080/10903120090941461
18.
DavidoffJ, FowlerR, GordonD, . Clinical evaluation of a novel intraosseous device for adults: prospective, 250-patient, multi-center trial. J Emerg Med Serv JEMS2005;30(10):20–3.
19.
GillumL, KovarJ.Powered intraosseous access in the prehospital setting: MCHD EMS puts the EZ-IO to the test. J Emerg Med Serv JEMS2005;30(suppl):24–5.
20.
BergRA. Emergency infusion of catecholamines into bone marrow. Am J Dis Child1984;138:810–1.
21.
NeishSR, MaconMG, MooreJWM, GraeberGM. Intraosseous infusion of hypertonic glucose and dopamine. Am J Dis Child1988;142: 878–80.
22.
JaimovichDG, ShabinoCL, RingerTV, PetersGR. Comparison of intraosseous and intravenous routes of anticonvulsant administration in a porcine model. Ann Emerg Med1989;18:842–6. DOI 10.1016/S0196-644(89)80208-2
23.
LathersCM, JimKF, SpiveyWH. A comparison of intraosseous and intravenous routes of administration for antiseizure agents. Epilepsia1989;30:472–9.
24.
OrlowskiJP, PorembkaDT, GallagherJM, LockremJD, VanLenteF.Comparison study of intraosseous, central intravenous, and peripheral intravenous infusions of emergency drugs. Am J Dis Child1990;144:112–7.
25.
PollackCVJr, PenderES, WoodallBN, ParksBR. Intraosseous administration of antibiotics: same-dose comparison with intravenous administration in the weanling pig. Ann Emerg Med1991;20:772–6. DOI 10.1016/S0196-0644(05)80840–6
26.
JaimovichDG, KumarA, FrancomS.Evaluation of intraosseous vs intravenous antibiotic levels in a porcine model. Am J Dis Child1991;145:946–9.
27.
JaimovichDG, KecskesS.Intraosseous infusion: a re-discovered procedure as an alternative for pediatric vascular access. Indian J Pediatr1991;58:329–34.
28.
BilelloJF, O'HairKC, KirbyWC, MooreJW. Intraosseous infusion of dobutamine and isoproterenol. Am J Dis Child1991;145:165–7.
29.
KentnerR, HaasT, GervaisH, HillerB, DickW.Pharmacokinetics and pharmacodynamics of hydroxyethyl starch in hypovolemic pigs: a comparison of peripheral and intraosseous infusion. Resuscitation1999;40:37–44. DOI 10.1016/S0300-9572(98)00121-X
30.
WenzelV, LindnerKH, AugensteinS, . Intraosseous vasopressin improves coronary perfusion pressure rapidly during cardiopulmonary resuscitation in pigs. Crit Care Med1999;27:1565–9.
31.
ChastagnerP, LozneiwskiA, LascombesP, Barberi-HeyobM, MerthesPM, MerlinJ.Pharmacokinetic longitudinal studies of antibiotics administered via a permanent intraosseous device in micropigs. Med Pediatr Oncol2001;36:635–40. DOI 10.1002/mpo.U41
32.
VoelckelWG, LurieKG, McKniteS, . Comparison of epinephrine with vasopressin on bone marrow blood flow in an animal model of hypovolemic shock and subsequent cardiac arrest. Crit Care Med2001;29:1587–92.
33.
FioritoBA, MirzaF, DoranTM, . Intraosseous access in the setting of pediatric critical care transport. Pediatr Crit Care Med2005;6:50–3.
34.
GuyJ, HaleyK, ZuspanSJ. Use of intraosseous infusions in the pediatric trauma patient. J Pediatr Surg1993;28:158–61. DOI 10.1016/S0022-3468(05):80263–5
35.
GlaeserPW, LosekJD, NelsonDB, . Pediatric intraosseous infusions: impact on vascular access time. Am J Emerg Med1988;6:330-2. DOI 10.1016/0735-6757(88)90149–0
36.
GlaeserPW, HellmichTR, SzewczugaD, . Five-year experience in prehospital intraosseous infusions in children and adults. Ann Emerg Med1993;22:1119–24. DOI 10.1016/S0196-0644(05)80975-8
37.
BanerjeeS, SinghiSC, SinghS, SinghM.The intraosseous route is a suitable alternative to intravenous route for fluid resuscitation in severely dehydrated children. Indian Pediatr1994;31:1511–20.
38.
SmithR, DavisN, BouamraO, LeckyF.The utilization of intraosseous infusion in the resuscitation of paediatric major trauma patients. Injury2005;36:1034–8.
39.
EngleWA. Intraosseous access for administration of medications in neonates. Clin Perinatal2006;33:161–8.
40.
EllemunterH, SimmaB, TrawogerR, MaurerH.Intraosseous lines in preterm and full term neonates. Arch Dis Child Fetal Neonatal Ed1999;80:F74–5.
41.
GrahamCA. Commentary to: The utilization of intraosseous infusion in the resuscitation of paediatric major trauma patients. Injury2005;36:1039.
42.
ValdesMM. Intraosseous fluid administration in emergencies. Lancet1977;1:1235–6.
43.
IsersonKV. Intraosseous infusion in adults. J Emerg Med1989;7:587–91. DOI 10.1016/0736-4679(89)90002–4
44.
WaismanM, WaismanD.Bone marrow infusion in adults. J Trauma1997;42:288–93.
45.
LaunayF, PautO, KatchburianM, BourelleS, JouveJL, BolliniG.Leg amputation after intraosseous infusion in a 7-month-old infant: a case report. J Trauma2003;55:788–90. DOI 10.1097/01.TA.0000025875.18050.A4
46.
FiallosM, KissoonN, AbdelmoneimT, . Fat embolism with the use of intraosseous infusion during cardiopulmonary resuscitation. Am J Med Sci1997;314:73–9.
47.
StollE, GolejJ, BurdaG, HermonM, BoignerH, TrittenweinG.Osteomyelitis at the injection site of adrenalin through an intraosseous needle in a 3-month-old infant. Resuscitation2002;53:315–8. DOI 10.1016/S0300-9572(02)00039-4
48.
BowleyDM, LovelandJ, PitcherGJ. Tibial fracture as a complication of intraosseous infusion during pediatric resuscitation. J Trauma2003;55:786–7. DOI 10.1097/01.TA.0000100170.61381.63
49.
FiserRT, WalkerWM, SeibertJJ, McCarthyR, FiserDH. Tibial length following intraosseous infusion: a prospective, radiographic analysis. Pediatr Emerg Care1997;13:186–8.
50.
ClaudetI, BauninC, Laporte-TurpinE, MarcouxMO, GrouteauE, CahuzacJP. Long-term effects on tibial growth after intraosseous infusion: a prospective, radiographic analysis. Pediatr Emerg Care2003;19:397–401.
